Anna E. Vilgelm

The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute

ORCID: 0000-0002-4446-913X

Also affiliated with The Ohio State University

MedicineBiochemistry, Genetics and Molecular BiologyImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 17 papers. Top paper: “Novel induction of CD40 expression by tumor cells with RAS/RAF/PI3K pathway inhibition augments response to checkpoint blockade”.

Novel induction of CD40 expression by tumor cells with RAS/RAF/PI3K pathway inhibition augments response to checkpoint blockade

Molecular Cancer(2021)10.1186/s12943-021-01366-y

N/A

1.4DataRank · unranked

39 citations

Nabil Saleh, Jinming Yang, Caroline A. Nebhan, Anna E. Vilgelm, E. Premkumar Reddy +7 more

Divergent paths of mammary gland involution: unveiling the cellular dynamics in abruptly and gradually involuted mouse models

Breast Cancer Research(2025)10.1186/s13058-024-01933-3

N/A

0.360DataRank · unranked

10 citations

Sanjay Mishra, Neelam Shinde, Maria C. Cuitiño, Morgan Bauer, Dinesh K. Ahirwar +11 more

High-throughput drug screening of fine-needle aspiration-derived cancer organoids

STAR Protocols(2020)10.1016/j.xpro.2020.100212

N/A

0DataRank · unranked

18 citations

Courtney J. Phifer, Vijaya Bharti, David Westover, Joshua A. Bauer, Anna E. Vilgelm +3 more

Obtaining patient-derived cancer organoid cultures via fine-needle aspiration

STAR Protocols(2020)10.1016/j.xpro.2020.100220

N/A

0DataRank · unranked

32 citations

Kensey Bergdorf, Matthew E. Bechard, Anna E. Vilgelm, Naira Baregamian, Oliver G. McDonald +3 more

Correlative studies investigating effects of PI3K inhibition on peripheral leukocytes in metastatic breast cancer: potential implications for immunotherapy

Breast Cancer Research and Treatment(2020)10.1007/s10549-020-05846-5

N/A

0DataRank · unranked

6 citations

Caroline A. Nebhan, Jinming Yang, Lauren S. Starnes, Chi Yan, Anna E. Vilgelm +6 more

Cell Therapy With TILs: Training and Taming T Cells to Fight Cancer

Frontiers in Immunology(2021)10.3389/fimmu.2021.690499

N/A

0DataRank · unranked

143 citations

Reese Watkins, Anna E. Vilgelm, Amrendra Kumar

Metabolic modulation by CDK4/6 inhibitor promotes chemokine-mediated recruitment of T cells into mammary tumors

Cell Reports(2021)10.1016/j.celrep.2021.108944

N/A

0DataRank · unranked

101 citations

Vijaya Bharti, Zhufeng Ouyang, Ashlyn Blevins, Stacey Mont, Nabil Saleh +9 more

Fine-Needle Aspiration-Based Patient-Derived Cancer Organoids

iScience(2020)10.1016/j.isci.2020.101408

N/A

0DataRank · unranked

79 citations

Kensey Bergdorf, Melissa M. Wolf, Vijaya Bharti, Rebecca L. Shattuck-Brandt, Ashlyn Blevins +19 more

BCL-xL inhibition potentiates cancer therapies by redirecting the outcome of p53 activation from senescence to apoptosis

Cell Reports(2022)10.1016/j.celrep.2022.111826

N/A

0DataRank · unranked

50 citations

Reese Watkins, Amrendra Kumar, Rebecca L. Shattuck-Brandt, Alexis Mossing, Arjun Mittra +11 more

Dendritic cell therapy augments antitumor immunity triggered by CDK4/6 inhibition and immune checkpoint blockade by unleashing systemic CD4 T-cell responses

Journal for ImmunoTherapy of Cancer(2023)10.1136/jitc-2022-006019

N/A

0DataRank · unranked

21 citations

Vijay Ramani, Vijaya Bharti, Daniel de Lima Bellan, Nabil Saleh, Roman V. Uzhachenko +6 more

Generation of Orthotopic Patient-Derived Xenografts in Humanized Mice for Evaluation of Emerging Targeted Therapies and Immunotherapy Combinations for Melanoma

Cancers(2023)10.3390/cancers15143695

N/A

0DataRank · unranked

11 citations

Caroline A. Nebhan, Nabil Saleh, Rebecca L. Shattuck-Brandt, Sheau‐Chiann Chen, Gregory D. Ayers +4 more

Illuminating the mechanism of IL-6-mediated immunotherapy resistance

Cell Reports Medicine(2023)10.1016/j.xcrm.2022.100901

N/A

0DataRank · unranked

8 citations

Anna E. Vilgelm

Generation of Orthotopic Patient-Derived Xenograft in Humanized Mice for Evaluation of Emerging Targeted Therapies and Immunotherapy Combinations for Melanoma

Preprints.org(2023)10.20944/preprints202307.0566.v1

N/A

0DataRank · unranked

3 citations

Caroline A. Nebhan, Nabil Saleh, Rebecca L. Shattuck-Brandt, Sheau‐Chiann Chen, Gregory D. Ayers +4 more

TTK inhibitor OSU13 promotes immunotherapy responses by activating tumor STING

JCI Insight(2024)10.1172/jci.insight.177523

N/A

0DataRank · unranked

10 citations

Amrendra Kumar, Yinchong Wang, N. Roy-Chowdhury, Daniel de Lima Bellan, Beimnet B. Kassaye +6 more

Host derived macrophage migration inhibitory factor expression attenuates anti-tumoral immune cell accumulation and promotes immunosuppression in the tumor microenvironment of head and neck squamous cell carcinoma

Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease(2024)10.1016/j.bbadis.2024.167345

N/A

0DataRank · unranked

10 citations

Felipe F. Lamenza, Suvekshya Shrestha, Puja Upadhaya, Anna Springer, Pete Jordanides +8 more

Treatment with Soluble CD24 Attenuates COVID-19-Associated Systemic Immunopathology

medRxiv(2021)10.1101/2021.08.18.21262258

N/A

0DataRank · unranked

3 citations

Carter Allen, Anna E. Vilgelm, Brian Riesenberg, Kevin P. Weller, Kelsi Reynolds +25 more

Metastatic Melanoma Patient–Derived Xenografts Respond to MDM2 Inhibition as a Single Agent or in Combination with BRAF/MEK Inhibition

Clinical Cancer Research(2020)10.1158/1078-0432.ccr-19-1895

N/A

0DataRank · unranked

48 citations

Sheau‐Chiann Chen, Emily Murray, Christopher Andrew Johnson, Holly Crandall, Jamye F. O’Neal +14 more